Assignee
MERSANA THERAPEUTICS INC
US·33 granted patents·28 pending applications·356 citations·filing 2011–2025
Top patents by PatentIndex Score
61 records- 0198US8815226B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2012·Granted Aug 26, 2014·54 cites·8 claims
- 0297US9144615B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 29, 2015·19 cites·22 claims
- 0397US8821850B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Sep 2, 2014·20 cites·18 claims
- 0496US9738720B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·10 cites·30 claims
- 0596US8349308B2Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2011·Granted Jan 8, 2013·141 cites·31 claims
- 0695US11155567B2Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·6 cites·14 claims
- 0795US8808679B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Aug 19, 2014·26 cites·20 claims
- 0894US10947317B2NaPi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 16, 2021·9 cites·15 claims
- 0994US9555112B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2015·Granted Jan 31, 2017·13 cites·42 claims
- 1093US10143695B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·7 cites·25 claims
- 1193US9254339B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Feb 9, 2016·16 cites·20 claims
- 1292US12156870B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Dec 3, 2024·1 cites·30 claims
- 1392US9770519B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·2 cites·21 claims
- 1489US11135307B2Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Oct 5, 2021·4 cites·8 claims
- 1589US2025066489A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1687US11939343B2Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2021·Granted Mar 26, 2024·1 cites·11 claims
- 1786US10660901B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2018·Granted May 26, 2020·2 cites·25 claims
- 1885US11596694B2Compositions and methods for predicting response to NaPi2b-targeted therapyMERSANA THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·4 cites·8 claims
- 1985US10603386B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·1 cites·18 claims
- 2083US10526294B2Pyrrolobenzodiazepines and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·5 cites·29 claims
- 2182US2023265197A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2281US9872918B2Hydroxyl-polymer-drug-protein conjugatesMERSANA THERAPEUTICS INC·Filed 2013·Granted Jan 23, 2018·2 cites·14 claims
- 2380US12440576B2Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 2480US9808528B2Protein-polymer-drug conjugates and methods of using sameMERSANA THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·2 cites·20 claims
- 2580US2025352662A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2679US9943609B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2016·Granted Apr 17, 2018·2 cites·20 claims
- 2778US9849191B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2014·Granted Dec 26, 2017·3 cites·19 claims
- 2878US2024382611A1Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2978US2025011339A1Sting agonist compounds and methods of useMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3077US11407825B2NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2019·Granted Aug 9, 2022·3 cites·12 claims
- 3177US10226535B2Auristatin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2013·Granted Mar 12, 2019·2 cites·19 claims
- 3274US11518812B2Monoclonal antibodies against HER2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2019·Granted Dec 6, 2022·0 cites·14 claims
- 3374US10772971B2Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·1 cites·41 claims
- 3472US2024148887A1Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3571US2021106690A1Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3671US2024269306A1B7h4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3769US11964025B2Peptide-containing linkers for antibody-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2021·Granted Apr 23, 2024·0 cites·16 claims
- 3869US2017313778A1Monoclonal antibodies against her2 epitope and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3969US2022378749A1Antibody drug conjugates comprising sting agonistsMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4069US2023355787A1Compositions and methods for predicting response to napi2b-targeted therapyMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4167US11964024B2B7H4-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·30 claims
- 4267US11786605B2Site specific antibody-drug conjugates with peptide-containing linkersMERSANA THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·0 cites·8 claims
- 4364US10537645B2Protein-polymer-drug conjugatesMERSANA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·0 cites·20 claims
- 4463US2016022829A1Tubulysin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4561US2021301031A1Napi2b-targeted antibody-drug conjugates and methods of use thereofMERSANA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4660US2023398229A1Antibody drug conjugates comprising sting agonists, combinations and methods of useMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4759US2014017265A1Terminally Modified Polymers and Conjugates ThereofMERSANA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4858US2018243427A1Tubulysin compounds and conjugates thereofMERSANA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4957US2022332815A1NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOFMERSANA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5054US2024050585A1B7-h4-targeted antibody-drug conjugates for the treatment of cancerMERSANA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MERSANA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →